HighLight Capital

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology. Its proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glue to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Its lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. It was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Tripod Preclinical Research is a Contract Research Organization that specializes in providing preclinical research services to the biopharmaceutical and medical device industries. The company offers a comprehensive range of services, including drug safety evaluation for new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Tripod's expertise encompasses non-human primate disease models, pharmacological efficacy studies, early drug evaluation, and Good Laboratory Practices (GLP) toxicology. Additionally, the organization supports translational medicine and clinical trials, along with biological analysis and the management of biological sample banks. By delivering these services, Tripod aids drug developers and researchers in advancing their projects through the critical early stages of research and development.

MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

Thousand Oaks Biopharmaceuticals, Inc. is a biotechnology company based in Haimen, China, specializing in contract development and manufacturing services for the biopharmaceutical industry. Established in 2017, the company focuses on developing biopharmaceutical technologies that enhance the production of protein and vaccine compounds. It offers integrated control solutions designed to optimize production processes, improve protein expression, and reduce production scale. Additionally, Thousand Oaks provides personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services to its clients. The company also operates a healthcare receivable management platform that enhances patient collections, reduces operational costs, and increases revenue for healthcare providers through effective revenue cycle management and technology-driven solutions.

ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.

Inmagene Biopharmaceuticals Co. Ltd., founded in 2019 and headquartered in Shanghai, China, is a clinical-stage biotechnology company dedicated to researching and developing novel therapeutics for immunological and inflammatory diseases. The company focuses on creating innovative biomedical drugs to assist patients and healthcare providers in addressing immune-related conditions. Its product pipeline includes IMG-020, a protein drug designed to target IL-17A, developed by integrating Affibody’s protein therapeutics platform for enhanced potency and Albumod technology for extended half-life. Inmagene also has additional offices in Hangzhou and Beijing, China, further supporting its commitment to advancing healthcare solutions in the field of immunology.

Hope Medicine focuses on researching, developing, and commercializing innovative biopharmaceuticals aimed at enhancing the quality of life for patients with various prevalent diseases. The company specializes in translational medicine, utilizing insights from global research initiatives to create monoclonal antibodies, protein drugs, and other therapeutic options targeting endocrine, cardiovascular, and metabolic disorders. By addressing the needs of underserved patient populations, Hope Medicine strives to improve health outcomes and provide access to effective and affordable treatments.

Developer of peptide-leading drugs intended to serve the medical sector in China. The company is platform-based, specialized in the discovery of peptide-leading drugs, focusing on development, production, sale of large-capacity peptide libraries and development of technical services for the screening of new peptides.

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Artivila Therapeutics is a pharmaceutical company established in 2018 and based in Shenzhen, China. The company specializes in biotechnology and is dedicated to improving patient outcomes through innovative drug discovery. Utilizing an AI-powered platform, Artivila focuses on developing new therapeutic solutions for neurodegenerative diseases, cancers, and autoimmune diseases. Its integrated approach aims to consistently and efficiently deliver first-in-class drug candidates, positioning Artivila at the forefront of pharmaceutical research and development.

Biotheus Inc. is a biotechnology company founded in 2018 and headquartered in Zhuhai, China. The company specializes in the discovery and development of antibody-based therapeutics, focusing on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Its core research and development areas include tumor immunotherapy and treatments for metabolic diseases and other domestic health issues. Founded by Andy Tsun, Joanne Sun, and Xiaolin Liu, Biotheus is dedicated to advancing innovative solutions in the biopharmaceutical sector.

Biotheus Inc. is a biotechnology company founded in 2018 and headquartered in Zhuhai, China. The company specializes in the discovery and development of antibody-based therapeutics, focusing on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Its core research and development areas include tumor immunotherapy and treatments for metabolic diseases and other domestic health issues. Founded by Andy Tsun, Joanne Sun, and Xiaolin Liu, Biotheus is dedicated to advancing innovative solutions in the biopharmaceutical sector.

Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.

Imago BioSciences is a clinical-stage biotechnology company based in San Carlos, California, focused on developing innovative therapies for hematologic diseases, including leukemia and myelodysplastic syndromes. Established in 2012, the company specializes in small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme crucial for blood cell production in the bone marrow. Its lead candidate, Bomedemstat, is an orally available inhibitor of LSD1, being evaluated for its potential to modify the disease course in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers. Imago aims to translate advanced scientific insights into effective treatments that can significantly improve the quality and duration of life for patients facing these challenging conditions.

XINGYUN GROUP is a comprehensive services platform for global commodities in China, devoting to providing global channel operation, distribution, and supply chain services to brands, retailers, and international trade practitioners.

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Soocas (Shenzhen) Technology Co., Ltd. is a company based in Shenzhen, China, that specializes in the design and development of smart personal health care electronics. Founded in 2015, Soocas primarily focuses on electronic toothbrushes, offering various models such as the Soocas X3 Upgrade, Soocas X1 Lite, and Soocas H3S, which feature capabilities like high-frequency vibration, multiple cleaning modes, and USB charging. In addition to toothbrushes, the company also produces blow dryers and shaving razors that integrate with the Xiaomi ecosystem, enhancing users' personal care experiences. Soocas further supports its products with a mobile application that allows users to control their toothbrushes conveniently.

Shanghai Hanyu Medical Technology Co., Ltd. specializes in the research and development of medical devices aimed at treating heart valve diseases. Established in 2016 and headquartered in Shanghai, with an additional office in Beijing, the company is recognized as one of the pioneering domestic firms in the development, production, and sale of transcatheter mitral valve repair devices. Hanyu Medical's flagship product, ValveClamp, is designed for minimally invasive interventions to address mitral valve regurgitation, enabling surgeons to close heart valves efficiently during procedures.

Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.

ChosenMed is a Healthcare company based in Beijing.

GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

4inLook is a retail company based in Shanghai, China, specializing in color contact lenses. Founded in 2008, it operates over 300 specialty stores primarily located in shopping centers within first- and second-tier cities. The company offers more than 200 designs of color contact lenses targeted at women aged 18 to 30. In addition to its physical retail presence, 4inLook has expanded its operations online through platforms like Tmall, allowing customers to experience a seamless shopping experience. Consumers can place orders online, pick them up in-store, and make appointments for product trials, thereby enhancing their purchasing convenience.

Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.

Genetron Health is a world-leading expert in precision medicine.They are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology diagnosis, medication guidance and prognosis monitoring) and effectively applying genomic data to assist medical experts and research scientists. Additionally, they provide cancer patients and high-risk and healthy individuals with reliable molecular clinical services and professional cancer genetic risk assessment.In just three years, Genetron Health has built global genomics sequencing and bioinformatics platforms, established two research and development centers in both North Carolina, U.S., and Beijing, China, and set up clinical laboratories in Beijing, Shanghai, Hangzhou and Chongqing of over 10,000 square meters.In the future, Genetron Health will spread its sales network throughout China with professional marketing, product management, medical experts and scientific research teams, and will provide service for Chinese and global cancer patients with its strong foundation in cancer genomics and efficient clinical translation.

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.

Julikang is a third-party medical device disinfection supply service provider that can interface with hospital information systems (HIS systems) through sterile item traceability management software. After accessing the hospital HIS system, the whole process of traceability management of sterile articles was realized. In addition, Julikang directly accesses the equipment manufacturer interface to the traceability management software, which enables third-party disinfection suppliers to read the physical parameter information of the device in real time. .

Loving Care International Pet Hospital is a comprehensive animal medical institution that includes beauty, physical examination, vaccines, clinics, etc., and provides users with prevention information on common dog diseases, common cat diseases, alternative pet diseases, and launches mobile animal service vehicles for pets. Provide home-based basic medical services.

Angstrom STEM is a brand of Anglia Education Group, integrating the resources and achievements of science and technology education of Shanghai Jiaotong University, and introducing the technology experience model of the United States and Canada, innovatively opening up STEM entertainment and education, integrating scientific experiments, model construction, mechanical energy, robot construction With programming, 3D printing, mathematics, etc., and focusing on the application and innovation of the latest science and technology, we have established a complete scientific STEM curriculum system to promote the quality education of domestic children and build a leading high-end STEM education brand in China.

Bitwise Asset Management, Inc., founded in 2016 and based in San Francisco, specializes in providing index and beta cryptoasset funds. Originally known as Locust Studios, Inc., the company rebranded in September 2017 to reflect its focus on cryptocurrency investment solutions. Bitwise serves a diverse clientele, including individuals, wealth managers, family offices, investment managers, and institutions, helping them navigate the complexities of the cryptocurrency market. The firm develops various financial products, including funds and indexes, and offers insights and services to enhance understanding of cryptoassets. With a team experienced in technology, security, and finance, Bitwise aims to bridge the gap between technical and non-technical audiences, fostering broader participation in the evolving crypto landscape.

Cullgen Inc. is a biopharmaceutical company based in San Diego, California, established in 2018. The company focuses on developing innovative new chemical entities (NCEs) aimed at treating diseases that currently lack effective therapeutic options. Utilizing its proprietary uSMITE™ platform, Cullgen employs targeted protein degradation technology to selectively degrade disease-causing proteins. This approach is particularly significant for addressing cancer, inflammatory, and autoimmune diseases, including targets that have been deemed undruggable. By providing novel therapeutic strategies, Cullgen aims to enhance drug discovery and offer new avenues for treating debilitating conditions.

Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on researching and developing biocatalytic and synthetic biology methods, which are applied to large-scale production across various sectors. Its innovations are utilized in pharmaceuticals, health care products, and pesticides, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a provider of bio-intelligent manufacturing solutions for chemical and biological products.

Imago BioSciences is a clinical-stage biotechnology company based in San Carlos, California, focused on developing innovative therapies for hematologic diseases, including leukemia and myelodysplastic syndromes. Established in 2012, the company specializes in small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme crucial for blood cell production in the bone marrow. Its lead candidate, Bomedemstat, is an orally available inhibitor of LSD1, being evaluated for its potential to modify the disease course in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers. Imago aims to translate advanced scientific insights into effective treatments that can significantly improve the quality and duration of life for patients facing these challenging conditions.

Baolulu Digital Medical Network Platform is an integrated platform for Internet-based digital medicine consisting of Baohulu Digital Medicine Series Software, Baohulu Digital Medicine Network, Baolulu Digital Medical Workstation and Baohulu Mobile Station. It is used to provide treatment for specialists around the world. A comprehensive service platform for software tool assistance, medical platform support, departmental services, and physician professional communication assistance, which is available to all specialists worldwide.

BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

VCBeat develops an online platform, which provides online news. The company was founded in 2014 and is headquartered in Chongqing, China.

Biotheus Inc. is a biotechnology company founded in 2018 and headquartered in Zhuhai, China. The company specializes in the discovery and development of antibody-based therapeutics, focusing on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Its core research and development areas include tumor immunotherapy and treatments for metabolic diseases and other domestic health issues. Founded by Andy Tsun, Joanne Sun, and Xiaolin Liu, Biotheus is dedicated to advancing innovative solutions in the biopharmaceutical sector.

MALO CLINIC was established in 1995 by Dr. Paulo Malo. Today is world’s leader in Implantology and Dental Cosmetic as well as an Educational Centre on Oral Rehabilitation that trains over 3,500 professionals coming from all over the world per year. Besides Dentistry MALO CLINIC expanded to other health specialties, projecting an innovative concept of Medical Spa through a strong bet in wellbeing which resulted in the foundation of a Health Management business group spread worldwide known as MALO CLINIC Health & Wellness.

Predicine Huidu Medical Technology Co., Ltd. is a medical and health company based in Fengxian, China. It specializes in technology research and development, focusing on creating a clinical application platform that connects patients with healthcare companies. By leveraging innovative solutions, Predicine aims to enhance the interaction between patients and the healthcare industry, facilitating better access to medical services and information.

Beijing Chemclin Biotech Co., Ltd. specializes in the development, production, and sales of diagnostic reagents and instruments for clinical use. Founded in 1999 and based in Beijing, China, the company focuses on in-vitro diagnostics, offering a range of products including reagents for infectious diseases, tumor markers, and thyroid and diabetes testing. Chemclin also provides semi-automated and fully automated chemiluminescent analyzers, which facilitate the performance of chemiluminescent assays. Additionally, the company offers commercial testing services for various health conditions, including liver fibrosis and fertility. As a subsidiary of China Diagnostics Medical Corporation, Chemclin is committed to delivering innovative diagnostic solutions and services to the Chinese healthcare market.

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Chowsing Live, based in Shanghai, China, specializes in the online retail of pet products and accessories. Founded in 2004, the company offers a diverse range of items including pet jumbo wipes, cat collars with bells, and flushable cat litters. In addition to these products, Shanghai Chowsing Company provides various pet services encompassing pet food, nutrition, toiletries, cleaning products, and medicine. Through its online platform, Chowsing Live aims to meet the needs of pet owners by offering convenient access to essential pet care items.

MoonBiotech is a Guangzhou-based healthcare startup that focuses on the development and research of microbe-based bioactive products for diverse applications. The company specializes in creating and screening high-quality microbial ingredients and fermentation products, catering to the needs of various industries such as biological agriculture, environmental governance, health food, and biomedicine. By providing valuable microbiological resources, MoonBiotech aims to address the increasing demand for innovative solutions in these sectors.

ChosenMed is a Healthcare company based in Beijing.

GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

Kunya Medical is a medical equipment service company based in Shanghai, China, founded in 2009. The company specializes in the maintenance and servicing of imaging and radiation equipment, offering comprehensive management solutions for hospitals. Kunya Medical provides a range of services, including overall hosting of medical equipment, technical maintenance, installation, debugging, and equipment relocation. Additionally, the company supplies spare parts and equipment management software, catering to both domestic and international brands of large and medium-sized medical devices. By offering these services, Kunya Medical aims to enhance the management of medical equipment in hospitals and extend the operational lifespan of clinical devices.

Junhetang operates a network of traditional Chinese medicine (TCM) clinics, providing a range of healthcare services that include herbal medicine, acupuncture, massage, exercise, and dietary therapies. The company combines TCM culture with the expertise of renowned TCM practitioners to deliver personalized medical services. Additionally, Junhetang integrates modern internet services into its offerings, creating an innovative TCM service network that encompasses education, training, medical care, and health maintenance. Headquartered in Nanjing, the company is actively expanding its presence in several major cities across China, including Shanghai, Shenzhen, Chengdu, and Taiyuan.

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Sansure Biotech Inc. is a biotechnology company based in Changsha, China, specializing in molecular diagnosis and genetic testing. Founded in 2008, the company develops and sells a range of products including nucleic acid extraction kits, real-time PCR diagnostic and research kits, and fluorescence systems. Its product offerings cover various health concerns such as novel coronavirus detection, viral hepatitis, AIDS, blood screening, cancer-related biomarkers, and respiratory, sexually transmitted, digestive, and genetic diseases. Sansure Biotech serves hospitals and laboratories, providing essential diagnostic reagents, instruments, and consumables to support healthcare needs both domestically and internationally.

Loving Care International Pet Hospital is a comprehensive animal medical institution that includes beauty, physical examination, vaccines, clinics, etc., and provides users with prevention information on common dog diseases, common cat diseases, alternative pet diseases, and launches mobile animal service vehicles for pets. Provide home-based basic medical services.

Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.

Shanghai General Healthy Information and Technology Co., Ltd. specializes in pharmaceutical logistics automation and intelligent medical solutions. Based in Shanghai, China, the company offers a range of products designed for the efficient management of medicines in healthcare settings and pharmaceutical distribution. Key offerings include the Smart Pharmacy Project, which addresses out-patient pharmacy needs; the Intelligent Static Center Project, focused on intravenous admixture services; and the Intelligent Drug Consumables Management Project, aimed at optimizing the management of medical supplies. The company markets its solutions under various brands, including Kangchi, CONSIS, and SANTO, positioning itself as a key player in the integration of technology within the healthcare and pharmaceutical sectors.

Rundong Pharmaceutical R&D is a CRO company specializing in drug clinical research outsourcing and providing one-stop service. It is the main initiator and promoter of china CRO Alliance (CROU) and is now CROU. The president unit is the first CRO company in china's CRO industry to pass the ISO 9001:2008 quality management system combined with CRO industry standard certification.

It involves in the development of children''s physical and mental health management platform. Health Management Center Co., Ltd. engages in the provision of mobile internet parenting health guidance online interaction and offline services.

Tellyes Scientific Inc. is a manufacturer and marketer of healthcare equipment designed for medical education and training. Established in 2001 and based in Tianjin, China, the company specializes in a range of products, including patient simulators, surgical simulators, ultrasound and imaging simulators, task trainers, and dental simulators. Tellyes Scientific aims to enhance medical teaching capabilities by providing realistic simulation tools for research organizations, medical colleges, and hospitals. In addition to its product offerings, the company provides solutions for planning and building training centers, managing training centers, and tele-simulation. Its products are distributed across various regions, including Asia, Africa, the Middle East, Europe, North America, and Latin America.

Shanghai Gandong New Energy Technology Co., Ltd. provides rental services of electronic motorcycle. The firm is based in Shanghai, China.

Kunya Medical is a medical equipment service company based in Shanghai, China, founded in 2009. The company specializes in the maintenance and servicing of imaging and radiation equipment, offering comprehensive management solutions for hospitals. Kunya Medical provides a range of services, including overall hosting of medical equipment, technical maintenance, installation, debugging, and equipment relocation. Additionally, the company supplies spare parts and equipment management software, catering to both domestic and international brands of large and medium-sized medical devices. By offering these services, Kunya Medical aims to enhance the management of medical equipment in hospitals and extend the operational lifespan of clinical devices.

Kontour Medical, based in Xi'an, China, specializes in the research, development, production, and sale of implanted medical devices across various surgical fields, including neurosurgery, cardiovascular surgery, craniofacial surgery, and stomatology. Founded in 2005, the company's product offerings encompass a range of advanced medical solutions. In neurosurgery, Kontour provides titanium mesh for internal fixation, polyetheretherketone (PEEK) skull repair systems, and bioplate internal fixation systems. Its thoracic surgery line includes PEEK sternum fixation bands and rib plate systems. Additionally, Kontour develops neurospine products, such as cervical and lumbar internal fixation systems and interbody fusion cages. The company's oral implant systems feature titanium and titanium alloy dental implants, alongside other surgical products like hernia repair patches. Through its diverse portfolio, Kontour Medical aims to enhance surgical outcomes in multiple medical disciplines.

JunHe Law Offices, established in 1989 and headquartered in Beijing, is an independent law firm in China that offers a comprehensive range of legal services. The firm specializes in various areas, including bankruptcy, corporate mergers and acquisitions, dispute resolution, and intellectual property. It also provides expertise in capital markets, competition law, environmental, social, and governance matters, as well as regulatory compliance and project finance. JunHe serves clients across multiple sectors such as real estate, construction, banking, energy, and education, and it caters to both domestic and international clients, including those from Asia and Europe. The firm is recognized for its commitment to delivering high-quality legal counsel and adapting to the evolving needs of its diverse client base.

Shenzhen Annet Information System Co., Ltd. operates a medical information technology platform in Shenzhen, China. The company specializes in developing innovative products for hospitals, Internet hospitals, and medical associations, while also focusing on constructing medical big data systems. Annet Information System utilizes its proprietary Annet Heterogeneous Information Integration Platform and Annet Cloud Image Center to aggregate core medical treatment data from millions of patients. This integration allows for the seamless sharing of comprehensive medical information through mobile internet, cloud imaging, and artificial intelligence technologies. As a result, Annet aims to enhance the connectivity and efficiency of medical services across various healthcare institutions, facilitating comprehensive and continuous care for patients.

Genechem (China), officially known as Shanghai Genechem Co., Ltd., is a high-tech enterprise located in the Shanghai Zhangjiang Hi-Tech Park. The company specializes in providing research and development services focused on life science solutions that support gene research. It integrates various functions including genetic technology services, technological transformation, product development, and sales. Through its comprehensive offerings, Genechem aims to advance the field of genetics and contribute to innovations within the life sciences sector.

It involves in the development of children''s physical and mental health management platform. Health Management Center Co., Ltd. engages in the provision of mobile internet parenting health guidance online interaction and offline services.

Provider of an online platform designed to provide pharmaceutical marketing and promotion services. The company's online marketing platform is designed to offer pharmaceutical e-marketing, digital marketing services, remote conference, surgery-live broadcasting and patient assistance programs, enabling physicians and medical practitioners to engage in effective healthcare communication.

Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China. Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.

Quyi Network is a technology company based in China that specializes in providing a service platform for medical assistance. The platform facilitates online services such as booking appointments with doctors, accessing lab test results, and processing payments. By offering these features, Quyi Network enables users to obtain timely medical advice and information, enhancing the overall healthcare experience.

Shanghai Kyee Technology Co., Ltd. is a smart medical technology and service provider. The business scope includes smart ward, HRP, and medical cloud. Shanghai Kyee Technology Co., Ltd. was founded in 2004 and is based in Shanghai, China.

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Oranger is a developer of portable wearable medical devices, focused on the treatment of medical-grade chronic respiratory diseases such as sleep apnea.

iHear Medical, Inc. is a California-based company focused on providing affordable and accessible hearing solutions. Established in 2010 and headquartered in San Leandro, the company offers a range of web-enabled hearing aids and sound amplifiers, including the iHEARhd and iHEARMAX, which cater to varying degrees of hearing loss. iHear Medical addresses the significant gap in hearing aid usage, as only 14% of individuals with hearing loss currently use them, largely due to high costs and stigma. The company also developed the iHEARtest, an FDA-cleared at-home hearing screener that allows consumers to assess their hearing and determine the appropriate hearing aid solution based on a proprietary Hearing Number. The iHEARtest is available online and at select retail pharmacies. With over 50 patents submitted and a commitment to innovation, iHear Medical aims to enhance the quality of life for those with hearing loss through its comprehensive product offerings and services.